Inhibition of naïve class I‐restricted T cells by altered peptide ligands
- 1 August 1999
- journal article
- research article
- Published by Wiley in Immunology & Cell Biology
- Vol. 77 (4) , 318-323
Abstract
Amino acid variants of an antigenic peptide or altered peptide ligands have previously been investigated with CD4+ and CD8+ T cells. However, for CD8+ T cells, only clones (which are continually restimulated in vitro) have been assessed. Using TCR transgenic mice specific for a class I Kb‐restricted OVA peptide (OVAp; OT‐I mice) as a source of naïve CD8+ T cells, single amino acid variants of the OVAp were analysed in vitro for their ability to antagonize the proliferative and cytotoxic function of naïve OT‐I cells. Peptides with substitutions at TCR contact residues were found to be the most potent antagonists of OT‐I cell function. Those peptides that inhibited activation of cells to proliferate also inhibited activation of cells to become killers. Inhibition was inversely correlated with interferon (IFN)‐γ production. It was found that levels of antagonist peptide required for inhibition were higher than that described for T cell clones, presumably due to affinity differences.Keywords
Funding Information
- Diabetes Australia
- National Health and Medical Research Council
This publication has 32 references indexed in Scilit:
- A TCR Binds to Antagonist Ligands with Lower Affinities and Faster Dissociation Rates Than to AgonistsImmunity, 1996
- Partial T cell signaling: Altered phospho-? and lack of zap70 recruitment in APL-induced T cell anergyCell, 1994
- Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variantsNature, 1994
- Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cellsNature, 1994
- Tickling the TCR: selective T-cell functions stimulated by altered peptide ligandsImmunology Today, 1993
- The Biochemistry and Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1993
- Crystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2K bScience, 1992
- Identification of an autologous insulin B chain peptide as a target antigen for H-2Kb-restricted cytotoxic T lymphocytes.Journal of Experimental Medicine, 1992
- Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptorCell, 1992
- Introduction of soluble protein into the class I pathway of antigen processing and presentationCell, 1988